| Dawn Marie Farrell, PT | |
|
65 Van Buren St, Mastic, NY 11950-4123 | |
| (631) 399-0114 | |
| Not Available |
| Full Name | Dawn Marie Farrell |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist - Pediatrics |
| Location | 65 Van Buren St, Mastic, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881735546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251P0200X | Physical Therapist - Pediatrics | 014623-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Marie Farrell, PT 65 Van Buren St, Mastic, NY 11950-4123 Ph: (631) 399-0114 | Dawn Marie Farrell, PT 65 Van Buren St, Mastic, NY 11950-4123 Ph: (631) 399-0114 |
News Archive
Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
Ontario has one of the highest survival rates for breast cancer in the world, with nearly 90 per cent of women surviving the disease, yet, more than half a million women eligible for Ontario's Breast Screening Program (OBSP) are not getting screened.
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
Acusphere, Inc. today announced that it had completed the Marketing Authorisation Application dossier for its lead product candidate, Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension, and is now starting the process of filing the MAA dossier with the European Medicines Agency to support the regulatory review of Imagify in the European Union.
› Verified 9 days ago
Jill Mandel, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1636 Montauk Hwy, Mastic, NY 11950 Phone: 631-399-0007 | |
Ms. Erika Votruba, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1636 Montauk Hwy, Mastic, NY 11950 Phone: 631-399-0007 | |
Mr. Justin J Bonacci, PT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1636 Montauk Hwy, Ste 4, Mastic, NY 11950 Phone: 631-399-0007 Fax: 631-399-2992 | |
Cathie Ellen Simon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1133 Montauk Hwy, Mastic, NY 11950 Phone: 631-467-4235 Fax: 631-467-2655 |